Partly, variably, and unpredictably — which is why the question matters in both directions

Published 26 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
IGF-1 immunoassays use antibodies against epitopes on the 70-residue protein. The LR3 analogue retains most of that surface, so many antibodies bind it, but the amino-terminal extension and the arginine at position 3 alter or mask epitopes in that region, and binding-protein-blocking steps in clinical assays assume the native molecule. Cross-reactivity therefore ranges from near-complete to negligible between kits and is rarely stated by the manufacturer. The analogue cannot be reliably quantified by an IGF-1 immunoassay, and IGF-1 cannot be reliably quantified in a sample that contains the analogue. Mass spectrometry resolves both problems by mass.

Why cross-reactivity varies

Monoclonal antibodies recognise a few residues. One directed at the B domain near the amino terminus may be blocked by the extension; one directed at the C or D domain binds the analogue as well as the native protein. Sandwich assays need two antibodies to bind simultaneously, so they are more sensitive to any change. Calibration is against native IGF-1, so even an antibody that binds the analogue may report it at a different apparent concentration.

The same problem affects measurement of every engineered protein with its parent assay.

Consequences

For a laboratory wanting the concentration of LR3 in a solution, chromatography against an LR3 standard or absorbance-based methods are the appropriate tools, not an IGF-1 kit. For a clinical IGF-1 result in anyone exposed to the analogue, the number is uninterpretable: it may include analogue, exclude it, or be suppressed by the feedback the analogue causes. For anti-doping, the variability is why confirmation is by mass spectrometry.

The culture-reagent manufacturers quantify by chromatography and bioassay for the same reason.

Why it is here

Because it is a practical analytical fact about the molecule that follows from its design, and because the question is often asked. It describes no use of the pack.

IGF-1 LR3 is supplied by REVIVE LAB UAE for laboratory research use only, with identity and purity documented for the batch. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
IGF-1 LR3 Pack1 mgAED 650In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

Why cross-reactivity varies?

Monoclonal antibodies recognise a few residues. One directed at the B domain near the amino terminus may be blocked by the extension; one directed at the C or D domain binds the analogue as well as the native protein. Sandwich assays need two antibodies to bind simultaneously, so they are more sensitive to any change. Calibration is against native IGF-1, so even an antibody that binds the analogue may report it at a different apparent concentration.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

IGF-1 LR3 Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.